# Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

> **NCT03864458** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 207 (actual)

## Conditions studied

- Hyperphosphatemia

## Interventions

- **DRUG:** KHK7791
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03864458
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-15
- **Primary completion:** 2019-12-10
- **Final completion:** 2019-12-31
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03864458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03864458, "Dose-finding Study of KHK7791 in Hyperphosphatemia Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03864458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*